Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/164390
Title: Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy
Authors: Zhang, Yijing
Li, Jingchao
Pu, Kanyi
Keywords: Science::Chemistry
Issue Date: 2022
Source: Zhang, Y., Li, J. & Pu, K. (2022). Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy. Biomaterials, 291, 121906-. https://dx.doi.org/10.1016/j.biomaterials.2022.121906
Project: NRFNRFI07-2021-0005 
2019-T1-002-045, 
RG125/19 
RT05/20) 
MOE-T2EP30220-0010 
MOE-T2EP30221-0004 
Journal: Biomaterials 
Abstract: Nanomedicines have been regarded as a potential approach in the field of cancer treatment due to their unique advantages. Although improved therapeutic efficacy can be achieved, the applications of most traditional nanomedicines are still limited by severe side effects resulting from unintended retention of therapeutic agents in non-diseased tissues. To increase the controllability of therapeutic agent accumulation in targeting sites (such as tumors), stimuli-responsive nanomedicines that realize drug release in response to exogenous or endogenous stimuli have been developed. In these stimuli-responsive nanomedicines, most of them are activated by mono type of stimulus, and therefore show unsatisfactory selectivity and specificity. In contrast, dual- and multi-responsive nanomedicines that integrate different responsive components into a signal nanoplatform can allow drug release in a more safe and effective manner, leading to both improved therapeutic efficacy and reduced systemic toxicity. Herein, we summarize recent advances in precision cancer therapy by using dual- and multi-responsive nanomedicines. The design strategies and working mechanisms of these dual- and multi-responsive nanomedicines and their applications in chemotherapy, phototherapy, and immunotherapy of cancer are introduced in detail. The existing challenges and future prospects are finally discussed in anticipation of accelerating the clinical translation of these nanomedicines.
URI: https://hdl.handle.net/10356/164390
ISSN: 0142-9612
DOI: 10.1016/j.biomaterials.2022.121906
Schools: Lee Kong Chian School of Medicine (LKCMedicine) 
School of Chemistry, Chemical Engineering and Biotechnology 
Rights: © 2022 Elsevier Ltd. All rights reserved. This paper was published in Biomaterials and is made available with permission of Elsevier Ltd.
Fulltext Permission: embargo_20250107
Fulltext Availability: With Fulltext
Appears in Collections:CCEB Journal Articles
LKCMedicine Journal Articles

Files in This Item:
File Description SizeFormat 
Recent advances in dual and multi responsive nanomedicines for precision cancer therapy.pdf
  Until 2025-01-07
3.31 MBAdobe PDFUnder embargo until Jan 07, 2025

SCOPUSTM   
Citations 20

15
Updated on Apr 16, 2024

Web of ScienceTM
Citations 20

6
Updated on Oct 26, 2023

Page view(s)

134
Updated on Apr 21, 2024

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.